The 'Outperform' rating suggests that the analyst expects IQVIA to perform better than the market average, which is positive. However, the slight reduction in the price target from $270 to $265 indicates a minor adjustment in the expected valuation, which could be due to various factors such as market conditions or company performance. Overall, the impact is neutral as the rating remains positive but with a slightly lower target.